Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 79
Filtrar
2.
Br Dent J ; 202(11): 643, 2007 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-17595603
4.
Aliment Pharmacol Ther ; 20(6): 645-55, 2004 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-15352913

RESUMEN

BACKGROUND: Non-steroidal anti-inflammatory drugs use may protect against development of oesophageal adenocarcinoma. AIM: To define the consequences of non-steroidal anti-inflammatory drugs use in patients with Barrett's oesophagus. METHODS: Records of all Barrett's oesophagus/oesophageal adenocarcinoma patients examined in Blackpool-Wyre-Fylde area were reviewed. All surviving patients completed validated questionnaires. RESULTS: Use of non-steroidal anti-inflammatory drugs of any type and at any frequency was more prevalent in Barrett's oesophagus patients [147 (38%) Barrett's oesophagus vs. 30 (26%) oesophageal adenocarcinoma, P = 0.02]. Daily use of non-steroidal anti-inflammatory drugs was more prevalent in Barrett's oesophagus patients [88 (23%) Barrett's oesophagus vs. 14 (12%) oesophageal adenocarcinoma, P = 0.02], due to more prevalent consumption of non-aspirin non-steroidal anti-inflammatory drugs [48 (13%) Barrett's oesophagus vs. four (4%) oesophageal adenocarcinoma, P = 0.009]. There was no difference between the two groups in usage of either daily low-dose aspirin or of occasional non-steroidal anti-inflammatory drugs. In logistic regression analysis any use of non-steroidal anti-inflammatory drugs [odds ratio (OR) = 0571 (95% CI: 0.359-0.909), P = 0.018] and daily use of non-aspirin non-steroidal anti-inflammatory drugs [OR = 0.297 (95% CI: 0.097-0.911), P = 0.034] were significant protective factors. Non-steroidal anti-inflammatory drugs use did not affect the survival of oesophageal adenocarcinoma patients. Oesophageal adenocarcinoma and Barrett's oesophagus consuming non-steroidal anti-inflammatory drugs did not differ in upper gastrointestinal bleeding [26 (15%) non-steroidal anti-inflammatory drugs consumers vs. 29 (9%) non-consumers, P = 0.08], oesophageal ulcers [31 (18%) non-steroidal anti-inflammatory drug consumers vs. 49 (15%) non-consumers, P = 0.43] or stricturing [19 (11%) non-steroidal anti-inflammatory drug consumers vs. 41 (13%) non-consumers, P = 0.58]. CONCLUSIONS: (i) Daily use of non-steroidal anti-inflammatory drugs is more prevalent in Barrett's oesophagus than oesophageal adenocarcinoma patients, because of a more prevalent use of non-aspirin non-steroidal anti-inflammatory drugs. (ii) Use of non-steroidal anti-inflammatory drugs in Barrett's oesophagus patients is safe if acid suppression is adequate.


Asunto(s)
Adenocarcinoma/prevención & control , Antiinflamatorios no Esteroideos/uso terapéutico , Esófago de Barrett/tratamiento farmacológico , Neoplasias Esofágicas/prevención & control , Adenocarcinoma/patología , Anciano , Antiinflamatorios no Esteroideos/efectos adversos , Esófago de Barrett/patología , Biopsia/métodos , Neoplasias Esofágicas/patología , Esófago/patología , Femenino , Hemorragia Gastrointestinal/inducido químicamente , Humanos , Masculino , Úlcera Péptica/inducido químicamente , Análisis de Supervivencia
7.
Dig Liver Dis ; 35(4): 275-82, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12801040

RESUMEN

BACKGROUND: One of the available treatments for unresectable oesophagogastric malignancies is the insertion of metal stents. AIMS: We evaluated prospectively 147 patients suffering from malignant dysphagia and/or fistula, after inserting a self-expandable metal stent. PATIENTS AND METHODS: The study included 147 patients (87 males, mean age 73 years). Dysphagia before and after stent placement was scored. Patients were divided in two groups according to dysphagia grade: group A (grade 0, 1) and group B (grades 2, 3, 4). Three types of stents were used: the Ultraflex stent (covered and uncovered) and the Flamingo one (covered). The total number of self-expandable metal stents placed was 183. A total of 92 of them were inserted following the combined endoscopic and fluoroscopic approach (42 by injecting lipiodol), while 91 were placed under endoscopic control only. Early and late complications were evaluated. RESULTS: Mean dysphagia score in group A, 1 day and 1 month after the procedure, was slightly reduced from 0.8 to 0.5/0.6 (p=NS), respectively. However, there was a statistically significant improvement (p<0.001) of mean dysphagia score in group B, from 2.4 initially to 1.1/1.4. Early complications occurred in 37 cases, late ones in 51. According to severity, minor complications occurred in 24 patients, major in 42, while life-threatening ones in 22. Survival ranged from 1 to 611 days and 1-week mortality was 9%. Stent-related death occurred in six patients. CONCLUSIONS: All kinds of endoscopic methods used for stenting in the present study were easy to perform even on an out-patient basis. Insertion of self-expandable metal stents is effective in patients with dysphagia scores > or = 2. It might not clinically improve patients with dysphagia score <2, so selection of patients for stenting is essential to avoid unnecessary procedures. Moreover, their high cost, high complication rates and low overall survival may improve following better selection criteria.


Asunto(s)
Trastornos de Deglución/terapia , Fístula Esofágica/terapia , Cuidados Paliativos/métodos , Stents , Adenocarcinoma/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/complicaciones , Trastornos de Deglución/clasificación , Trastornos de Deglución/etiología , Fístula Esofágica/etiología , Neoplasias Esofágicas/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Stents/efectos adversos , Análisis de Supervivencia
8.
J Clin Child Psychol ; 30(1): 48-58, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11294077

RESUMEN

Highlights the desirability of using a theoretical framework for guiding the design and evaluation of therapeutic interventions for children with attention deficit hyperactivity disorder (ADHD). A general conceptual model is introduced and used to evaluate ADHD treatment outcome research. Treatments designed to target the substrate level (pharmacological interventions) result in broad, robust improvement in both core and peripheral areas of functioning. Those targeting hypothesized core features of the disorder (i.e., attention, impulsivity-hyperactivity) produce corresponding improvement in core and peripheral outcome measures with the exception of studies employing cognitive-behavior therapy. Those targeting peripheral features of the disorder effect change only in corresponding peripheral areas of functioning. Implications for clinical practice are discussed, and an alternative conceptual model of ADHD is introduced and compared with existing models.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/psicología , Trastorno por Déficit de Atención con Hiperactividad/terapia , Estimulantes del Sistema Nervioso Central/uso terapéutico , Modelos Psicológicos , Psicoterapia/métodos , Atención , Terapia Conductista , Niño , Terapia Cognitivo-Conductual , Humanos , Conducta Impulsiva , Socialización
9.
Radiology ; 218(3): 873-80, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11230669

RESUMEN

PURPOSE: To prospectively compare full-field digital mammography (FFDM) with screen-film mammography (SFM) for cancer detection in a screening population. MATERIALS AND METHODS: At two institutions, 4,945 FFDM examinations were performed in women aged 40 years and older presenting for SFM. Two views of each breast were acquired with each modality. SFM and FFDM images were interpreted independently. Findings detected with either SFM or FFDM were evaluated with additional imaging and, if warranted, biopsy. RESULTS: Patients in the study underwent 152 biopsies, which resulted in the diagnosis of 35 breast cancers. Twenty-two cancers were detected with SFM and 21 with FFDM. Four were interval cancers that became palpable within 1 year of screening and were considered false-negative findings with both modalities. The difference in cancer detection rate was not significant. FFDM had a significantly lower recall rate (11.5%; 568 of 4,945) than SFM (13.8%; 685 of 4,945) (P <.001, McNemar chi(2) model; P <.03, generalized estimating equations model). The positive biopsy rate for findings detected with FFDM (30%; 21 of 69) was higher than that for findings detected with SFM (19%; 22 of 114), but this difference was not significant. CONCLUSION: No difference in cancer detection rate has yet been observed between FFDM and SFM. FFDM has so far led to fewer recalls than SFM.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Mamografía/métodos , Intensificación de Imagen Radiográfica/métodos , Biopsia , Neoplasias de la Mama/patología , Reacciones Falso Negativas , Femenino , Estudios de Seguimiento , Humanos , Interpretación de Imagen Asistida por Computador , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Curva ROC , Sensibilidad y Especificidad
11.
J Clin Child Psychol ; 29(4): 555-68, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11126633

RESUMEN

Reviews the usefulness of clinic-based and laboratory-based instruments and paradigms for diagnosing attention deficit hyperactivity disorder (ADHD) and monitoring treatment effects. Extant literature examining the performance of normal children and those with ADHD on an extensive range of neurocognitive tests, tasks, and experimental paradigms indicates that particular types of instruments may be more reliable than others with respect to detecting between-group differences. We review task parameters that may distinguish the more reliable from less reliable instruments. The value of clinic-based and laboratory-based instruments for monitoring treatment response in children with ADHD is questionable when evaluated in the context of ecologically relevant variables such as classroom behavior and academic functioning. We present a general conceptual model to highlight conceptual issues relevant to designing clinic-based and laboratory-based instruments for the purposes of diagnosing and monitoring treatment effects in children with ADHD. Application of the model to currently conceptualized core variables indicates that attention and impulsivity-hyperactivity may represent correlative rather than core features of the disorder. We discuss implications of these findings for designing the next generation of clinic-based and laboratory-based instruments.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Conducta Infantil/clasificación , Niño , Psiquiatría Infantil/métodos , Humanos , Memoria , Pruebas Neuropsicológicas , Variaciones Dependientes del Observador , Grupo Paritario , Psicometría , Análisis y Desempeño de Tareas
13.
Eur J Gastroenterol Hepatol ; 9(9): 913-5, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9355793

RESUMEN

A case is presented of caecal tuberculosis coexisting with adenocarcinoma at the same site, unusually presenting as a right iliac fossa abscess. The relevant literature on 61 previously reported patients with coexisting tuberculosis and colonic carcinoma is reviewed. The patient was 81-years-old, female with a tender swelling in the right iliac fossa. Following examination by ultrasound, laparotomy was undertaken which revealed a large abscess cavity contaminated by Mycobacterium tuberculosis. Although anti-tuberculosis treatment was given, there was a persistent purulent discharge from the wound, so a new ultrasound, computed tomography scan and barium enema were arranged. These could not clearly differentiate between ileocaecal tuberculosis and carcinoma. A second laparotomy showed that there was an underlying adenocarcinoma. Although rare, the coexistence of colonic tuberculosis with carcinoma should be seriously considered especially in patients who fail to respond to anti-tuberculosis treatment. A definitive diagnosis can be established only by histological examination.


Asunto(s)
Adenocarcinoma/complicaciones , Enfermedades del Colon/complicaciones , Neoplasias del Colon/complicaciones , Tuberculosis Gastrointestinal/complicaciones , Adenocarcinoma/diagnóstico por imagen , Anciano , Anciano de 80 o más Años , Sulfato de Bario , Enfermedades del Colon/diagnóstico por imagen , Neoplasias del Colon/diagnóstico por imagen , Enema , Resultado Fatal , Femenino , Humanos , Tomografía Computarizada por Rayos X , Tuberculosis Gastrointestinal/diagnóstico por imagen
15.
Eur J Gastroenterol Hepatol ; 8(11): 1121-4, 1996 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8944377

RESUMEN

This report concerns four patients in a district general hospital who died from malignant liver tumours associated with Thorotrast (thorium dioxide) deposits in the liver. Three were known to have had diagnostic angiographic studies performed 36 to 43 years previously using Thorotrast as the contrast agent. In the fourth case no previous relevant information could be obtained. There were two men and one woman with hepatocellular carcinoma and one woman with cholangiocarcinoma. In one of the hepatoma cases there was associated hypercalcaemia of malignancy. Reported latency intervals suggest that cases of Thorotrast-related hepatic malignancy may present up to the second decade of the twenty-first century.


Asunto(s)
Neoplasias de los Conductos Biliares/inducido químicamente , Carcinógenos/efectos adversos , Carcinoma Hepatocelular/inducido químicamente , Colangiocarcinoma/inducido químicamente , Neoplasias Hepáticas/inducido químicamente , Dióxido de Torio/efectos adversos , Anciano , Anciano de 80 o más Años , Neoplasias de los Conductos Biliares/patología , Neoplasias de los Conductos Biliares/fisiopatología , Carcinoma Hepatocelular/patología , Carcinoma Hepatocelular/fisiopatología , Colangiocarcinoma/patología , Colangiocarcinoma/fisiopatología , Conducto Colédoco , Resultado Fatal , Femenino , Humanos , Neoplasias Hepáticas/patología , Neoplasias Hepáticas/fisiopatología , Masculino , Persona de Mediana Edad , Factores de Riesgo , Factores de Tiempo
16.
Behav Modif ; 20(4): 428-30, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8875814

RESUMEN

The effectiveness of four doses (5-mg, 10-mg, 15-mg, 20-mg) of methylphenidate (MPH) and attentional training (AT) were evaluated using neurocognitive instruments (Continuous Performance Test; Matching Unfamiliar Figures Test), narrow- and broad-band rating scales in the context of a double-blind, placebo-control, within-subject reversal design for dizygotic twin girls with Attention-Deficit/Hyperactivity Disorder (ADHD). Both interventions proved effective for improving neurocognitive test performance and behavior, although broad-band ratings revealed dose-response curves different from those obtained from the neurocognitive tests. Implications for clinical management of girls with ADHD are discussed.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/genética , Terapia Conductista , Estimulantes del Sistema Nervioso Central/administración & dosificación , Enfermedades en Gemelos/genética , Discapacidades para el Aprendizaje/genética , Metilfenidato/administración & dosificación , Atención/efectos de los fármacos , Trastorno por Déficit de Atención con Hiperactividad/psicología , Trastorno por Déficit de Atención con Hiperactividad/terapia , Terapia Combinada , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Esquema de Medicación , Femenino , Humanos , Discapacidades para el Aprendizaje/terapia , Actividad Motora/efectos de los fármacos , Pruebas Neuropsicológicas , Determinación de la Personalidad , Gemelos Dicigóticos/genética , Gemelos Dicigóticos/psicología
18.
Gut ; 37(5): 731-3, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8549954

RESUMEN

Linear IgA dermatosis is a malignancy associated rare bullous disorder similar to dermatitis herpetiformis. Linear IgA dermatosis differs from dermatitis herpetiformis in that the IgA deposits in the epidermal basement membrane are linear rather than granular. A patient is presented with coeliac disease who presented with linear IgA dermatosis and anaemia caused by chronic low grade B cell lymphoma.


Asunto(s)
Enfermedad Celíaca/complicaciones , Linfoma de Células B/complicaciones , Enfermedades Cutáneas Vesiculoampollosas/complicaciones , Anciano , Enfermedad Celíaca/dietoterapia , Resultado Fatal , Femenino , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...